Fenretinide: all 45 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung CancerRecruitingNCT06922539Phase 1
• Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaRecruitingNCT04234048Phase 1
• A Study to Evaluate the Safety of Fenretinide in Healthy VolunteersCompletedNCT06181760Phase 1Results posted
• Study of LAU-7b for the Treatment of Long COVID in AdultsCompletedNCT05999435Phase 2/3Results posted
• Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in AdultsTerminatedNCT04417257Phase 2/3Results posted
• Study of LAU-7b in the Treatment of Cystic Fibrosis in AdultsCompletedNCT03265288Phase 2Results posted
• A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With ObesitySuspendedNCT00546455Phase 2Results posted
• Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaTerminatedNCT00288067Phase 1/2Results posted
• Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate CancerCompletedNCT00080899Phase 2Results posted
• Study to Examine the Effects of Oral FenretinideCompletedNCT06528457Phase 2
• Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell LymphomasStatus unknownNCT02495415Phase 2
• Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant NeuroblastomaTerminatedNCT02163356Phase 1
• Safety Study of Fenretinide in Adult Patients With Cystic FibrosisCompletedNCT02141958Phase 1
• Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed MalignanciesTerminatedNCT01553071Phase 1
• Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian CancerTerminatedNCT01535157Phase 1/2
• Fenretinide in Healthy Young Women at Genetic and Familial RiskTerminatedNCT01479192Phase 3
• Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHLTerminatedNCT01187810Phase 1
• N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant NeuroblastomaCompletedNCT00646230Phase 1
• Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia PatientsWithdrawnNCT00534898Phase 3
• Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular DegenerationCompletedNCT00429936Phase 2
• Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsCompletedNCT00387504Phase 1
• Fenretinide in Treating Patients With Refractory or Relapsed Hematologic CancerCompletedNCT00104923Phase 1
• 4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)TerminatedNCT00102635Phase 1
• Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the OvariesCompletedNCT00098800Not applicable
• Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate CancerCompletedNCT00077402Phase 2
• Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma MultiformeTerminatedNCT00075491Phase 2
• Fenretinide in Treating Children With Recurrent or Resistant NeuroblastomaCompletedNCT00053326Phase 2
• Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00026091Phase 2
• Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased RiskTerminatedNCT00017134Not applicable
• Chemotherapy in Treating Patients With Advanced Kidney CancerCompletedNCT00011973Phase 2
• Fenretinide in Treating Patients With Recurrent Small Cell Lung CancerCompletedNCT00009971Phase 2
• Combination Chemotherapy in Treating Patients With Solid TumorsStatus unknownNCT00009932Phase 1
• Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00006471Phase 2
• Fenretinide in Treating Patients With Recurrent Malignant GliomaCompletedNCT00006080Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00005819Phase 1
• Fenretinide in Treating Patients With Leukoplakia of the MouthCompletedNCT00004161Phase 2
• Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder CancerCompletedNCT00004154Phase 3
• Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus SyndromeCompletedNCT00003601Phase 2
• Fenretinide in Treating Patients With Solid TumorsCompletedNCT00003250Phase 1
• SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the MouthTerminatedNCT00003223Phase 2
• Fenretinide in Treating Children With Solid TumorsCompletedNCT00003191Phase 1
• Chemoprevention Therapy Plus Surgery in Treating Women With Breast CancerCompletedNCT00003099Phase 2
• Fenretinide in Treating Patients With Cervical NeoplasiaCompletedNCT00003075Phase 3
• Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast CancerCompletedNCT00002646Phase 3
• A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast CancerCompletedNCT00001378Phase 1

← Fenretinide overview